Watch Presentations & Learn More About Upcoming Presenters
Event Co-Sponsor

KCSA

January 20th Agenda
 
10:30 AM ET
IM Cannabis Corp.

Nasdaq: IMCC | CSE: IMCC
Oren Shuster, Chief Executive Officer & Director

11:00 AM ET
MariMed Inc.

OTCQX: MRMD
Robert Fireman, Founder & CEO

11:30 AM ET
Verano Holdings Corp.

OTCQX: VRNOF | CSE: VRNO
Julianna Paterra, CFA - Director, Investor Relations

12:00 PM ET
Keynote Presentation: 2022 Cannabis Outlook

Aaron Grey, CFA, CPA
Managing Director, Equity Research - Consumer & Cannabis
Alliance Global Partners

12:30 PM ET
Fire & Flower Holdings Corp.

OTCQX: FFLWF | TSX: FAF
Trevor Fencott, Chief Executive Officer

1:00 PM ET
The Valens Company Inc.

Nasdaq: VLNS | TSX: VLNS
Everett Knight, Executive VP, Corporate Development & Capital Markets

1:30 PM ET
InMed Pharmaceuticals Inc.

Nasdaq: INM
Eric Adams, President & CEO
Shane Johnson, SVP and General Manager of BayMedica

2:00 PM ET
Flower One Holdings Inc.

OTCQX: FLOOF | CSE: FONE
Kellen O’Keefe, President & CEO

2:30 PM ET
Cannara Biotech Inc.

OTCQB: LOVFF | TSX-V: LOVE
Nicholas Sosiak, Chief Financial Officer

3:00 PM ET
NewLake Capital Partners, Inc.

OTCQX: NLCP
David Weinstein, CEO
Anthony Coniglio, President and CIO

3:30 PM ET
CV Sciences, Inc.

OTCQB: CVSI
Joseph Dowling, CEO

4:00 PM ET
Unrivaled Brands, Inc.

OTCQX: UNRV
Frank Knuettel, CEO

January 19th Agenda - Available for On-Demand Viewing
 
11:00 AM ET
Innocan Pharma Corp.

OTCQB: INNPF | CSE: INNO
Iris Bincovich, CEO

11:30 AM ET
GreenLane Holdings, Inc.

Nasdaq: GNLN
Nick Kovacevich, CEO

12:00 PM ET
Columbia Care Inc.

OTCQX: CCHWF | CSE: CCHW
Jesse Channon, Chief Growth Officer

12:30 PM ET
TILT Holdings Inc.

OTCQX: TLLTF | NEO: TILT
Gary Santo, CEO

1:00 PM ET
iPower Inc.

Nasdaq: IPW
Kevin Vassily, Chief Financial Officer

1:30 PM ET
Christina Lake Cannabis Corp.

OTCQB: CLCFF | CSE: CLC
Joel Dumaresq, CEO, BOD

2:00 PM ET
Nextleaf Solutions Ltd.

OTCQB: OILFF | CSE: OILS
Paul Pedersen, CEO

2:30 PM ET
Delta 9 Cannabis Inc.

OTCQX: DLTNF | TSX: DN
Ian Chadsey, VP IR & Corporate Affairs